To view the PDF file, sign up for a MySharenet subscription.

FERRUM CRESCENT LIMITED - Change to board

Release Date: 19/02/2014 15:00
Code(s): FCR     PDF:  
Wrap Text
Change to board

FERRUM CRESCENT LIMITED
(Incorporated and registered in Australia and registered as an external company in the Republic of
South Africa)
(Registration number A.C.N. 097 532 137)
(External company registration number 2011/116305/10)
Share code on the ASX: FCR
Share code on AIM: FCR
Share code on the JSE: FCR ISIN: AU000000FCR2
("Ferrum Crescent", the "Company")


MANAGING DIRECTOR APPOINTED FOR BFS COMPLETION

Ferrum Crescent, the ASX, AIM and JSE quoted iron ore developer, today announces the
appointment of Mr Tom Revy as CEO and Managing Director of the Company. Mr Revy will take up
his appointment and become an executive board member of Ferrum Crescent with immediate
effect. Mr Bob Hair will move to the position of Executive Director from Managing Director.

Mr Revy is a mining professional with 30 years’ experience specialising in operations, project
development and corporate management. His appointment brings a wealth of experience in project
development and planning to Ferrum Crescent as the Company progresses its bankable feasibility
study (“BFS”) towards construction readiness. As Development Director at Worley Parsons Mr Revy
worked extensively on the Olympic Dam Expansion and undertook key studies for companies such as
AngloAmerican and Codelco. Previously Mr Revy worked at design and construction group, GRD
Minproc, working on projects such as the Fortescue Metals phase 2 expansions in Western Australia
and on the US$1.8B project Tenke Fungurume project in the DRC.

Ferrum Crescent’s flagship project, the Moonlight Iron Ore Project (“Moonlight”) in Limpopo
province of South Africa, is currently moving through its Bankable Feasibility Study.

Commenting today Tom Revy, Managing Director, said: “I welcome the opportunity to work with
the Ferrum Crescent team for the exciting period that lies before us. The Moonlight Project is well
located for both development and product export logistics. The technical aspects of the Project are
sound so the focus over the next 6 months will be to optimise the financial return whilst reinforcing
our relationships with both Government and the local communities.”

Mr Ed Nealon, Chairman of Ferrum Crescent, said: “Tom’s appointment as CEO is perfect timing as
we look to move forward with the Moonlight BFS. His experience working on a series of major
mining projects needing high levels of infrastructure coordination will be extremely valuable to
Ferrum Crescent. I look forward to 2014, working with Tom and his team and our process
engineering partners, Danieli, as we progress towards construction readiness. I would also like to
thank Bob Hair for all his work as Managing Director and for his continued support of Ferrum. ”

Thomas George Revy (aged 50) is currently non-executive Chairman of Coppermoly Limited and
Empire Resources Limited, non-executive director of Resmin plc and director of Geminin Resources
Pty Ltd.

In the last five years Mr Revy has also held directorships with Energio Limited (now Kogi Iron
Limited), GRD Minproc Limited and Australia Latin America Business Council.

Under the terms of Mr Revy’s employment contract with Ferrum Crescent –
   (a) the term of employment commences today, 19 February 2014 and continues until
       terminated (Ferrum Crescent may terminate the employment effective immediately upon
       notice, Mr Revy may terminate the employment on 6 months’ notice (except in prescribed
       circumstances where termination is effective immediately upon notice));
   (b) Mr Revy is to carry out the responsibilities of managing director of the Company, nominally
       based in Perth, Western Australia, and to be accountable to the Company’s board of
       directors;
   (c) Mr Revy is to be paid an initial gross salary of A$250,000 per annum plus superannuation at
       a rate of 12%;
   (d) Mr Revy has been granted a total of 2,500,000 options to acquire fully paid ordinary shares
       in the capital of the Company (“Options”), expiring 19 February 2017 with an exercise price
       of A$0.08, and with certain performance conditions attached to the Options that must be
       satisfied before they can be exercised; and
   (e) the employment is subject to the usual terms and conditions relating to annual leave, sick
       leave, reimbursement of expenses incurred in the conduct of business for the Company,
       protection of the Company’s inventions and other intellectual property rights and
       compliance with the Company’s code of conduct, share trading policy and other applicable
       charters and policies.

For more information, please visit www.ferrumcrescent.com or contact:

Australia and Company enquiries:

Ferrum Crescent Limited
Ed Nealon T: +61 8 9380 9653
Executive Chairman

Tom Revy T: +61 8 9380 9653
Managing Director

UK enquiries:

Pareto Securities Ltd (Broker)
Guy Wilkes T: +44 (0) 20 7786 4370

RFC Ambrian Limited (Nominated Adviser)
Sarah Wharry/Stuart Laing
T: +44 (0) 20 3440 6800

Ferrum Crescent Limited
Laurence Read (UK representative)
T: +44 7557672432

South Africa enquiries:
Sasfin Capital
Leonard Eiser T: +27 11 809 7500
Appendix 3X

Initial Director’s Interest Notice


Information or documents not available now must be given to ASX as soon as available. Information
and documents given to ASX become ASX’s property and may be made public.
Introduced 30/9/2001.




Name of entity             FERRUM CRESCENT LIMITED

ABN         58 097 532 137



We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the
director for the purposes of section 205G of the Corporations Act.



                                                                 Thomas Revy
 Name of Director
 Date of appointment                                             19 February 2014



Part 1 - Director’s relevant interests in securities of which the director is the registered holder
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust



Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
 Number & class of securities
 2,500,000 unlisted Options. Exercisable at AU$0.08, expiring 19 February 2017




 Part 2 – Director’s relevant                                    Number & class of Securities
 interests in securities of which
 the director is not the registered
 holder In the case of a trust, this includes
 interests in the trust made available by the
 responsible entity of the trust Name of
 holder & nature of interest
 Note: Provide details of the circumstances giving rise to
 the relevant interest.
                                                                 N/A




Part 3 – Director’s interests in contracts


Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.




 Detail of contract                                              N/A

 Nature of interest                                              N/A




 Name of registered holder                                       N/A

 (if issued securities)



 No. and class of securities to which                            N/A
 interest relates
Appendix 3B

New issue announcement,
application for quotation of additional securities
and agreement


Information or documents not available now must be given to ASX as soon as available. Information and documents given
to ASX become ASX’s property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12




Name of entity
Ferrum Crescent Limited



ABN
58 097 532 137



We (the entity) give ASX the following information.




Part 1 - All issues
You must complete the relevant sections (attach sheets if there is not enough space).




 1        +Class  of +securities issued or to           Unlisted Options
          be issued




 2   Number of +securities issued or to            2,500,000 Unlisted Options
     be issued (if known) or maximum
     number which may be issued
3    Principal terms of the +securities            Unlisted Options issued pursuant to the terms
     (eg, if options, exercise price and           and conditions of Managing Director’s
     expiry date; if partly paid
     +securities, the amount outstanding          engagement contract. Exercisable at AU$0.08
     and due dates for payment; if                expiring 19 February 2017
     +convertible      securities,    the
     conversion price and dates for
     conversion)



4    Do the +securities rank equally in            Expire 19 February 2017/AU$0.08 exercise
     all respects from the date of                 price
     allotment with an existing +class of
     quoted +securities?

     If the additional securities do not
     rank equally, please state:
     ? the date from which they do
     ? the extent to which they
         participate for the next
         dividend, (in the case of a trust,
         distribution)      or     interest
         payment
     ? the extent to which they do not
         rank equally, other than in
         relation to the next dividend,
         distribution or interest payment


5    Issue price or consideration             AU$0.08 exercise price




6    Purpose of the issue                     Issued pursuant to the terms and conditions of
     (If issued as consideration for the
                                              the Managing Director’s engagement contract.
     acquisition of assets, clearly
     identify those assets)




6a   Is the entity an +eligible entity that   Yes
     has obtained security holder
     approval under rule 7.1A?

     If Yes, complete sections 6b – 6h
     in relation to the +securities the
     subject of this Appendix 3B, and
     comply with section 6i
6b   The date the security holder           29 November 2013
     resolution under rule 7.1A was
     passed


6c   Number of +securities issued           -
     without security holder approval
     under rule 7.1


6d   Number of +securities issued with      -
     security holder approval under rule
     7.1A


6e   Number of +securities issued with      48,000,000 ordinary shares
     security holder approval under rule
     7.3, or another specific security
     holder approval (specify date of
     meeting)
                                            29 November 2013



6f   Number of securities issued under      2,500,000 unlisted Options
     an exception in rule 7.2



6g   If securities issued under rule        N/A
     7.1A, was issue price at least 75%
     of 15 day VWAP as calculated
     under rule 7.1A.3? Include the
     issue date and both values.
     Include the source of the VWAP
     calculation.


6h   If securities were issued under rule   N/A
     7.1A for non-cash consideration,
     state date on which valuation of
     consideration was released to ASX
     Market Announcements


6i   Calculate the entity’s remaining       N/A
     issue capacity under rule 7.1 and
     rule 7.1A – complete Annexure 1
     and release to ASX Market
     Announcements


7    Dates of entering +securities into     19 February 2014
     uncertificated holdings or despatch
     of certificates
                                              Number                   +Class


 8     Number and +class of all               374,007,777              Ordinary shares
       +securities    quoted on ASX
       (including the securities in section
       2 if applicable)



                                              Number                   +Class



 9     Number and +class of all               6,595,000                Ordinary shares
       +securities not quoted on ASX

       (including the securities in section   3,400,000                Options
       2 if applicable)




 10    Dividend policy (in the case of a      The Directors will consider an appropriate
       trust, distribution policy) on the
                                              dividend policy once FCR has achieved the
       increased capital (interests)
                                              necessary profits.



                                              There is currently no dividend policy in place
                                              for the Company.




Part 2 - Bonus issue or pro rata issue


 11    Is    security   holder     approval
       required?




 12    Is the issue renounceable or non-
       renounceable?



 13    Ratio in which the +securities will
       be offered



 14    +Class  of +securities to which the
       offer relates
15   +Record  date   to   determine
     entitlements




16   Will holdings on different registers
     (or subregisters) be aggregated for
     calculating entitlements?


17   Policy for deciding entitlements in
     relation to fractions




18   Names of countries in which the
     entity has +security holders who
     will not be sent new issue
     documents
     Note: Security holders must be told how
     their entitlements are to be dealt with.

     Cross reference: rule 7.7.




19   Closing date for receipt of
     acceptances or renunciations

20   Names of any underwriters




21   Amount of any underwriting fee or
     commission



22   Names of any brokers to the issue




23   Fee or commission payable to the
     broker to the issue



24   Amount of any handling fee
     payable to brokers who lodge
     acceptances or renunciations on
     behalf of +security holders
 25      If the issue is contingent on
         +security holders’ approval, the date

         of the meeting


 26      Date entitlement and acceptance
         form and prospectus or Product
         Disclosure Statement will be sent to
         persons entitled


 27      If the entity has issued options, and
         the terms entitle option holders to
         participate on exercise, the date on
         which notices will be sent to option
         holders


 28      Date rights trading will begin (if
         applicable)



 29      Date rights trading will end (if
         applicable)




 30      How do +security holders sell their
         entitlements in full through a
         broker?


 31      How do +security holders sell part
         of their entitlements through a
         broker and accept for the balance?


 32      How do +security holders dispose
         of their entitlements (except by sale
         through a broker)?


 33      +Despatch   date




Part 3 - Quotation of securities
You need only complete this section if you are applying for quotation of securities



 34      Type of securities
         (tick one)
 (a)           Securities described in Part 1




 (b)           All other securities
                Example: restricted securities at the end of the escrowed period, partly paid securities that become fully
               paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of
               convertible securities




Entities that have ticked box 34(a)


Additional securities forming a new class of securities




Tick to indicate you are providing the information or
documents



             - the securities are and the number andthe names of the 20 largest holdersheld the
 35          If the + securities are +equity securities+ the names of the 20 largest holders of the 
             + additional securities and the number and percentage of additional securities held by
             those holders

               


  36           - the securities  are +equity securities,a distribution schedule of the additional +securities setting out                                                                  +
              the number of holders in the catagories
               1 - 1,000
               1,001 - 5,000
               5,001 - 10,000
               10,001 - 100,000
               100,001 and over


                                                                    
  37           - copy of any trust deed for the additional +securities
           

Entities that have ticked box 34(b)


 38     Number of securities for which
        +quotation is sought




 39     Class of +securities         for       which
        quotation is sought
40    Do the +securities rank equally in all
      respects from the date of allotment
      with an existing +class of quoted
      +securities?


      If the additional securities do not
      rank equally, please state:
      - the date from which they do
      - the extent to which they
          participate for the next dividend,
          (in the case of a trust,
          distribution) or interest payment
      - the extent to which they do not
          rank equally, other than in
          relation to the next dividend,
          distribution or interest payment


41    Reason for request for quotation
      now
      Example: In the case of restricted securities,
      end of restriction period




      (if issued upon conversion of
      another security, clearly identify that
      other security)




                                                       

42    Number and +class of all +securities
      quoted on ASX (including the
      securities in clause 38)




Quotation agreement


1     +Quotation   of our additional +securities is in ASX’s absolute discretion. ASX may quote the
      +securities on any conditions it decides.




2     We warrant the following to ASX.



       -       The issue of the +securities to be quoted complies with the law and is not for an
               illegal purpose.
        -      There is no reason why those +securities should not be granted +quotation.



        -      An offer of the +securities for sale within 12 months after their issue will not require
               disclosure under section 707(3) or section 1012C(6) of the Corporations Act.
               Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this

               warranty



 
        -      Section 724 or section 1016E of the Corporations Act does not apply to any

               applications received by us in relation to any +securities to be quoted and that no-

               one has any right to return any +securities to be quoted under sections 737, 738 or

               1016F of the Corporations Act at the time that we request that the +securities be

               quoted.




        -      If we are a trust, we warrant that no person has the right to return the +securities to
               be quoted under section 1019B of the Corporations Act at the time that we request
               that the +securities be quoted.



3      We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action
       or expense arising from or connected with any breach of the warranties in this agreement.



4      We give ASX the information and documents required by this form. If any information or
       document not available now, will give it to ASX before +quotation of the +securities begins.
       We acknowledge that ASX is relying on the information and documents. We warrant that
       they are (will be) true and complete.



Sign here:     ......................................................          Date: 19 February 2014

(Director/Company secretary)

Print name:    Andrew Nealon
Appendix 3B – Annexure 1

                                                                   +
Calculation of placement capacity under rule 7.1 and rule 7.1A for eligible entities
Introduced 01/08/12




Part 1



 Rule 7.1 – Issues exceeding 15% of capital

 Step 1: Calculate “A”, the base figure from which the placement
 capacity is calculated

 Insert number of fully paid ordinary
 securities on issue 12 months before date
 of issue or agreement to issue

 Add the following:
 •   Number of fully paid ordinary securities
     issued in that 12 month period under an
     exception in rule 7.2
 •   Number of fully paid ordinary securities
     issued in that 12 month period with
     shareholder approval
 •   Number of partly paid ordinary
     securities that became fully paid in that
     12 month period
 Note:

 •   Include only ordinary securities here –
     other classes of equity securities cannot
     be added

 •   Include here (if applicable) the securities
     the subject of the Appendix 3B to which
     this form is annexed

 •   It may be useful to set out issues of
     securities on different dates as separate
     line items


 Subtract the number of fully paid ordinary
 securities cancelled during that 12 month
 period

 “A”
Step 2: Calculate 15% of “A”

“B”                                             0.15
                                                [Note: this value cannot be changed]

Multiply “A” by 0.15

Step 3: Calculate “C”, the amount of placement capacity under rule 7.1
that has already been used

Insert number of equity securities issued or
agreed to be issued in that 12 month period
not counting those issued:
•   Under an exception in rule 7.2
•   Under rule 7.1A
•   With security holder approval under rule
    7.1 or rule 7.4
Note:

•   This applies to equity securities, unless
    specifically excluded – not just ordinary
    securities

•   Include here (if applicable ) the
    securities the subject of the Appendix
    3B to which this form is annexed

•   It may be useful to set out issues of
    securities on different dates as separate
    line items

“C”

Step 4: Subtract “C” from [“A” x “B”] to calculate remaining
placement capacity under rule 7.1

“A” x 0.15
Note: number must be same as shown in
Step 2

Subtract “C”
Note: number must be same as shown in
Step 3

Total [“A” x 0.15] – “C”
                                                [Note: this is the remaining placement
                                                capacity under rule 7.1]
Part 2



         Rule 7.1A – Additional placement capacity for eligible entities

 Step 1: Calculate “A”, the base figure from which the placement
 capacity is calculated

 “A”
 Note: number must be same as shown in
 Step 1 of Part 1

 Step 2: Calculate 10% of “A”

 “D”                                              0.10
                                                  Note: this value cannot be changed

 Multiply “A” by 0.10

 Step 3: Calculate “E”, the amount of placement capacity under rule
 7.1A that has already been used

 Insert number of equity securities issued or
 agreed to be issued in that 12 month period
 under rule 7.1A
 Notes:

 •   This applies to equity securities – not
     just ordinary securities

 •   Include here – if applicable – the
     securities the subject of the Appendix
     3B to which this form is annexed

 •   Do not include equity securities issued
     under rule 7.1 (they must be dealt with
     in Part 1), or for which specific security
     holder approval has been obtained

 •   It may be useful to set out issues of
     securities on different dates as separate
     line items

 “E”




 Step 4: Subtract “E” from [“A” x “D”] to calculate remaining
 placement capacity under rule 7.1A
 “A” x 0.10
 Note: number must be same as shown in
 Step 2

 Subtract “E”
 Note: number must be same as shown in
 Step 3

 Total [“A” x 0.10] – “E”
                                                 Note: this is the remaining placement
                                                 capacity under rule 7.1A

19 February 2014

Johannesburg

Sponsor

Sasfin Capital (a division of Sasfin Bank Limited)

Date: 19/02/2014 03:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Share This Story